106
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Co-administration of aspirin and adipose-derived stem cell conditioned medium improves the functional recovery of the optic pathway in a lysolecithin-induced demyelination model

, ORCID Icon, ORCID Icon, , &
Pages 2681-2694 | Published online: 17 Sep 2019

References

  • Ghasemi‐Kasman M, Zare L, Baharvand H, Javan M. In vivo conversion of astrocytes to myelinating cells by miR-302/367 and valproate to enhance myelin repair. J Tissue Eng Regen Med. 2018;12(1):e462–e472. doi:10.1002/term.227628127945
  • Yousefi F, Ebtekar M, Soudi S, Soleimani M, Hashemi SM. In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Immunol Lett. 2016;172:94–105. doi:10.1016/j.imlet.2016.02.01626930038
  • Mondal S, Jana M, Dasarathi S, Roy A, Pahan K. Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11–mediated protection of regulatory T cells. Sci Signal. 2018;11(558):eaar8278. doi:10.1126/scisignal.aar827830482850
  • Mulakayala N, Rao P, Iqbal J, Bandichhor R, Oruganti S. Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: a brief overview. Eur J Med Chem. 2013;60:170–186. doi:10.1016/j.ejmech.2012.10.05523291119
  • Jadasz JJ, Kremer D, Göttle P, et al. Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation. PLoS One. 2013;8(8):e71814. doi:10.1371/journal.pone.007181423951248
  • Kotter MR, Stadelmann C, Hartung H-P. Enhancing remyelination in disease—can we wrap it up? Brain. 2011;134(7):1882–1900. doi:10.1093/brain/awr01421507994
  • Chen J, Zuo S, Wang J, et al. Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion. Front Aging Neurosci. 2014;6:7. doi:10.3389/fnagi.2014.0000724478700
  • Zafranskaya MM, Nizheharodova DB, Yurkevich MY, et al. In vitro assessment of mesenchymal stem cells immunosuppressive potential in multiple sclerosis patients. Immunol Lett. 2013;149(1–2):9–18. doi:10.1016/j.imlet.2012.10.01023089549
  • Dazzi F, Krampera M. Mesenchymal stem cells and autoimmune diseases. Best Pract Res Clin Haematol. 2011;24(1):49–57. doi:10.1016/j.beha.2011.01.00221396592
  • Cuascut FX, Hutton GJ. Stem cell-based therapies for multiple sclerosis: current perspectives. Biomedicines. 2019;7(2):26. doi:10.3390/biomedicines7020026
  • Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature Rev Immunol. 2008;8(9):726. doi:10.1038/nri239519172693
  • Davoodian N, Lotfi AS, Soleimani M, Mowla SJ. MicroRNA-122 overexpression promotes hepatic differentiation of human adipose tissue-derived stem cells. J Cell Biochem. 2014;115(9):1582–1593. doi:10.1002/jcb.2482224733606
  • Lin F. Adipose tissue–derived mesenchymal stem cells: a fat chance of curing kidney disease? Kidney Int. 2012;82(7):731–733. doi:10.1038/ki.2012.15822975993
  • Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells. 2013;2013:1–35.
  • Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105(4):1815–1822. doi:10.1182/blood-2004-04-155915494428
  • Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol. 2011;24(1):59–64. doi:10.1016/j.beha.2011.01.00421396593
  • Mammana S, Gugliandolo A, Cavalli E, et al. Human Gingival Mesenchymal Stem Cells (GMSCs) pre-treated with vesicular Moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury. J Tissue Eng Regen Med. 2019. doi:10.1002/term.2857
  • Rivera FJ, Couillard-Despres S, Pedre X, et al. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells. 2006;24(10):2209–2219. doi:10.1634/stemcells.2005-061416763198
  • Bai L, Lennon DP, Eaton V, et al. Human bone marrow‐derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57(11):1192–1203. doi:10.1002/glia.2084119191336
  • Cantinieaux D, Quertainmont R, Blacher S, et al. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One. 2013;8(8):e69515. doi:10.1371/journal.pone.006951524013448
  • Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int. 2014;2014:1–14.
  • Noverina R, Widowati W, Ayuningtyas W, et al. Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs). Clin Nutr Exp. 2019;24:34–44. doi:10.1016/j.yclnex.2019.01.002
  • Wei X, Zhao L, Zhong J, et al. Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis. Neurosci Lett. 2009;462(1):76–79. doi:10.1016/j.neulet.2009.06.05419549558
  • Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res. 2009;3(1):63–70. doi:10.1016/j.scr.2009.02.00619411199
  • Yazdi A, Khanghahi AM, Baharvand H, Javan M. Fingolimod enhances oligodendrocyte differentiation of transplanted human induced pluripotent stem cell-derived neural progenitors. Iran J Pharm Res. 2018;17(4):1444.30568702
  • Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. Neurol Res. 2012;34(9):854–858. doi:10.1179/1743132812Y.000000008122979982
  • Wingerchuk DM, Benarroch E, O’Brien P, et al. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology. 2005;64(7):1267–1269. doi:10.1212/01.WNL.0000156803.23698.9A15824361
  • Tsau S, Emerson MR, Lynch SG, LeVine SM. Aspirin and multiple sclerosis. BMC Med. 2015;13(1):153. doi:10.1186/s12916-015-0394-426123634
  • Huang N, Chen D, Wu X, et al. Aspirin promotes oligodendroglial differentiation through inhibition of Wnt signaling pathway. Mol Neurobiol. 2016;53(5):3258–3266. doi:10.1007/s12035-015-9241-z26059811
  • Modi KK, Sendtner M, Pahan K. Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin implications for remyelination in multiple sclerosis. J Biol Chem. 2013;288(25):18533–18545. doi:10.1074/jbc.M112.44726823653362
  • Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 1993;259(5095):689–692. doi:10.1126/science.84303208430320
  • Plemel JR, Michaels NJ, Weishaupt N, et al. Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy. Glia. 2018;66(2):327–347. doi:10.1002/glia.2324529068088
  • Sherafat MA, Javan M, Mozafari S, Mirnajafi-Zadeh J, Motamedi F. Castration attenuates myelin repair following lysolecithin induced demyelination in rat optic chiasm: an evaluation using visual evoked potential, marker genes expression and myelin staining. Neurochem Res. 2011;36(10):1887. doi:10.1007/s11064-011-0501-721626170
  • Baradaran S, Moghaddam AH, Ghasemi-Kasman M. Hesperetin reduces myelin damage and ameliorates glial activation in lysolecithin-induced focal demyelination model of rat optic chiasm. Life Sci. 2018;207:471–479. doi:10.1016/j.lfs.2018.07.00130056861
  • You Y, Gupta VK, Chitranshi N, Reedman B, Klistorner A, Graham SL. Visual evoked potential recording in a rat model of experimental optic nerve demyelination. JoVE. 2015;29(101):e52934.26273963
  • Naeimi R, Baradaran S, Ashrafpour M, Moghadamnia AA, Ghasemi-Kasman M. Querectin improves myelin repair of optic chiasm in lyolecithin-induced focal demyelination model. Biomed Pharmacother. 2018;101:485–493. doi:10.1016/j.biopha.2018.02.12529501770
  • Azandaryani ZS, Davoodian N, Samiei A, Rouzbehan S. Insulin-like growth factor-I promotes hepatic differentiation of human adipose tissue-derived stem cells. Cell Biol Int. 2019;43(5):476–485.
  • Shimojima C, Takeuchi H, Jin S, et al. Conditioned medium from the stem cells of human exfoliated deciduous teeth ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2016;196(10):4164–4171. doi:10.4049/jimmunol.150145727053763
  • Daneshdoust D, Khalili-Fomeshi M, Ghasemi-Kasman M, et al. Pregabalin enhances myelin repair and attenuates glial activation in lysolecithin-induced demyelination model of rat optic chiasm. Neuroscience. 2017;344:148–156. doi:10.1016/j.neuroscience.2016.12.03728049030
  • Hashemian M, Ghasemi-Kasman M, Parsian H, Sadeghi F. Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm. Brain Res Bull. 2019. doi:10.1016/j.brainresbull.2019.08.014
  • Naeimi R, Safarpour F, Hashemian M, et al. Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lysolecithin-induced focal demyelination model of rat corpus callosum. Neuroscience letters. 2018;674:1-10.
  • Ahmadian SR, Ghasemi-Kasman M, Pouramir M, Sadeghi F. Arbutin attenuates cognitive impairment and inflammatory response in pentylenetetrazol-induced kindling model of epilepsy. Neuropharmacology. 2019;146(1):117–127.
  • Gol M, Ghorbanian D, Hassanzadeh S, Javan M, Mirnajafi-Zadeh J, Ghasemi-Kasman M. Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model. Eur J Pharm Sci. 2017;96:72–83. doi:10.1016/j.ejps.2016.09.01627634580
  • Akbari A, Khalili-Fomeshi M, Ashrafpour M, Moghadamnia AA, Ghasemi-Kasman M. Adenosine A2A receptor blockade attenuates spatial memory deficit and extent of demyelination areas in lyolecithin-induced demyelination model. Life Sci. 2018;205:63–72. doi:10.1016/j.lfs.2018.05.00729730168
  • Fancy SP, Kotter MR, Harrington EP, et al. Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol. 2010;225(1):18–23. doi:10.1016/j.expneurol.2009.12.02020044992
  • Huang JK, Fancy SP, Zhao C, Rowitch DH, Franklin RJ. Myelin regeneration in multiple sclerosis: targeting endogenous stem cells. Neurotherapeutics. 2011;8(4):650–658. doi:10.1007/s13311-011-0065-x21904791
  • Mozafari S, Sherafat MA, Javan M, Mirnajafi-Zadeh J, Tiraihi T. Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Res. 2010;1351:50–56. doi:10.1016/j.brainres.2010.07.02620637745
  • Cruz-Martinez P, González-Granero S, Molina-Navarro M, et al. Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model. Cell Death Dis. 2016;7(5):e2223. doi:10.1038/cddis.2016.13027171265
  • Hao P, Liang Z, Piao H, et al. Conditioned medium of human adipose-derived mesenchymal stem cells mediates protection in neurons following glutamate excitotoxicity by regulating energy metabolism and GAP-43 expression. Metab Brain Dis. 2014;29(1):193–205. doi:10.1007/s11011-014-9490-y24458787
  • Yao C, Yang D, Wan Z, et al. Aspirin-triggered lipoxin A4 attenuates lipopolysaccharide induced inflammatory response in primary astrocytes. Int Immunopharmacol. 2014;18(1):85–89. doi:10.1016/j.intimp.2013.10.02824269179
  • Li Y, Gao X, Wang J. Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model. Exp Ther Med. 2018;15(2):1839–1846. doi:10.3892/etm.2017.560629434773
  • Heidari M, Pouya S, Baghaei K, et al. The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells‐conditioned medium in chronic colitis. J Cell Physiol. 2018;233(11):8754–8766. doi:10.1002/jcp.2676529797577
  • Sun H, Bénardais K, Stanslowsky N, et al. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in amyotrophic lateral sclerosis (ALS)-in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. PLoS One. 2013;8(9):e72926. doi:10.1371/journal.pone.007292624069165
  • Qie H, Fan S, Feng Z, Wang F, Hou X, Shan L. The inhibitory effect of mesenchymal stem cell conditioned medium on the secretion of inflammatory factor of human gingival fibroblast induced by lipopolysaccharide. Int J Clin Exp Med. 2018;11(6):5715–5721.
  • Pettit LK, Varsanyi C, Tadros J, Vassiliou E. Modulating the inflammatory properties of activated microglia with docosahexaenoic acid and aspirin. Lipids Health Dis. 2013;12(1):16. doi:10.1186/1476-511X-12-1623398903
  • Bae M-K, Kim S-R, Lee H-J, et al. Aspirin-induced blockade of NF-κB activity restrains up-regulation of glial fibrillary acidic protein in human astroglial cells. Biochim Et Biophys Acta (bba)-mol Cell Res. 2006;1763(3):282–289. doi:10.1016/j.bbamcr.2006.01.005